| Trial ID: | L3654 |
| Source ID: | NCT01232946
|
| Associated Drug: |
Liraglutide
|
| Title: |
Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01232946/results
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: liraglutide|DRUG: insulin detemir|DRUG: liraglutide plus insulin detemir
|
| Outcome Measures: |
Primary: Myocardial Glucose Uptake, PET measurements of myocardial glucose uptake will be done after 3 months of exposure to liraglutide, insulin detemir, or liraglutide plus insulin detemir, 3 months|Myocardial Fatty Acid Oxidation Rate, PET measurements of myocardial glucose uptake will be done after 3 months of exposure to liraglutide, insulin detemir, or liraglutide plus insulin detemir, 3 months|Myocardial Fatty Acid Esterification Rate, PET measurements of myocardial glucose uptake will be done after 3 months of exposure to liraglutide, insulin detemir, or liraglutide plus insulin detemir, 3 months |
|
| Sponsor/Collaborators: |
Sponsor: Indiana University | Collaborators: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
|
| Start Date: |
2012-01
|
| Completion Date: |
2017-09-08
|
| Results First Posted: |
2019-08-07
|
| Last Update Posted: |
2019-08-07
|
| Locations: |
Indiana Clinical Research Center, Indianapolis, Indiana, 46202, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01232946
|
